Literature DB >> 26531246

Impact of Plasmodium falciparum Coinfection on Longitudinal Epstein-Barr Virus Kinetics in Kenyan Children.

Arnold Reynaldi1, Timothy E Schlub2, Kiprotich Chelimo3, Peter Odada Sumba3, Erwan Piriou4, Sidney Ogolla3, Ann M Moormann5, Rosemary Rochford4, Miles P Davenport1.   

Abstract

Endemic Burkitt lymphoma is associated with Epstein-Barr virus (EBV) and Plasmodium falciparum coinfection, although how P. falciparum exposure affects the dynamics of EBV infection is unclear. We have used a modeling approach to study EBV infection kinetics in a longitudinal cohort of children living in regions of high and low malaria transmission in Kenya. Residence in an area of high malaria transmission was associated with a higher rate of EBV expansion during primary EBV infection in infants and during subsequent episodes of EBV DNA detection, as well as with longer episodes of EBV DNA detection and shorter intervals between subsequent episodes of EBV DNA detection. In addition, we found that concurrent P. falciparum parasitemia also increases the likelihood of the first and subsequent peaks of EBV in peripheral blood. This suggests that P. falciparum infection is associated with increased EBV growth and contributes to endemic Burkitt lymphoma pathogenesis.
© The Author 2015. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail journals.permissions@oup.com.

Entities:  

Keywords:  Burkitt lymphoma; Epstein-Barr virus; P. falciparum malaria; chronic infection; co-infection; infection dynamics

Mesh:

Year:  2015        PMID: 26531246      PMCID: PMC4760420          DOI: 10.1093/infdis/jiv525

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  20 in total

1.  Early age at time of primary Epstein-Barr virus infection results in poorly controlled viral infection in infants from Western Kenya: clues to the etiology of endemic Burkitt lymphoma.

Authors:  Erwan Piriou; Amolo S Asito; Peter O Sumba; Nancy Fiore; Jaap M Middeldorp; Ann M Moormann; Robert Ploutz-Snyder; Rosemary Rochford
Journal:  J Infect Dis       Date:  2012-02-01       Impact factor: 5.226

2.  Circulating epstein-barr virus in children living in malaria-endemic areas.

Authors:  N Rasti; K I Falk; D Donati; B A Gyan; B Q Goka; M Troye-Blomberg; B D Akanmori; J A L Kurtzhals; D Dodoo; R Consolini; A Linde; M Wahlgren; M T Bejarano
Journal:  Scand J Immunol       Date:  2005-05       Impact factor: 3.487

3.  On the dynamics of acute EBV infection and the pathogenesis of infectious mononucleosis.

Authors:  Vey Hadinoto; Michael Shapiro; Thomas C Greenough; John L Sullivan; Katherine Luzuriaga; David A Thorley-Lawson
Journal:  Blood       Date:  2007-11-08       Impact factor: 22.113

4.  Large-scale multiplex polymerase chain reaction assay for diagnosis of viral reactivations after allogeneic hematopoietic stem cell transplantation.

Authors:  Natsuko Inazawa; Tsukasa Hori; Naoki Hatakeyama; Masaki Yamamoto; Yuko Yoto; Masanori Nojima; Nobuhiro Suzuki; Norio Shimizu; Hiroyuki Tsutsumi
Journal:  J Med Virol       Date:  2015-05-06       Impact factor: 2.327

5.  Prospective evaluation of epstein-barr virus reactivation after stem cell transplantation: association with monoclonal gammopathy.

Authors:  Patrizia Chiusolo; Elisabetta Metafuni; Paola Cattani; Nicola Piccirillo; Rosaria Santangelo; Stefania Manzara; Silvia Bellesi; Teresa De Michele; Giuseppe Leone; Simona Sica
Journal:  J Clin Immunol       Date:  2010-08-25       Impact factor: 8.317

6.  Serological evidence for long-term Epstein-Barr virus reactivation in children living in a holoendemic malaria region of Kenya.

Authors:  Erwan Piriou; Rhonda Kimmel; Kiprotich Chelimo; Jaap M Middeldorp; Peter Sumba Odada; Robert Ploutz-Snyder; Ann M Moormann; Rosemary Rochford
Journal:  J Med Virol       Date:  2009-06       Impact factor: 2.327

Review 7.  The pathogenesis of Epstein-Barr virus persistent infection.

Authors:  David A Thorley-Lawson; Jared B Hawkins; Sean I Tracy; Michael Shapiro
Journal:  Curr Opin Virol       Date:  2013-05-15       Impact factor: 7.090

8.  Estimating cytomegalovirus growth rates by using only a single point.

Authors:  Deborah Cromer; Siok-Keen Tey; Rajiv Khanna; Miles P Davenport
Journal:  J Virol       Date:  2013-01-09       Impact factor: 5.103

9.  Sickle cell trait is not associated with endemic Burkitt lymphoma: an ethnicity and malaria endemicity-matched case-control study suggests factors controlling EBV may serve as a predictive biomarker for this pediatric cancer.

Authors:  David H Mulama; Jeffrey A Bailey; Joslyn Foley; Kiprotich Chelimo; Collins Ouma; Walter G Z O Jura; Juliana Otieno; John Vulule; Ann M Moormann
Journal:  Int J Cancer       Date:  2013-08-16       Impact factor: 7.396

10.  A multifactorial role for P. falciparum malaria in endemic Burkitt's lymphoma pathogenesis.

Authors:  Charles Torgbor; Peter Awuah; Kirk Deitsch; Parisa Kalantari; Karen A Duca; David A Thorley-Lawson
Journal:  PLoS Pathog       Date:  2014-05-29       Impact factor: 6.823

View more
  14 in total

1.  Modeling of EBV Infection and Antibody Responses in Kenyan Infants With Different Levels of Malaria Exposure Shows Maternal Antibody Decay is a Major Determinant of Early EBV Infection.

Authors:  Arnold Reynaldi; Timothy E Schlub; Erwan Piriou; Sidney Ogolla; Odada P Sumba; Ann M Moormann; Rosemary Rochford; Miles P Davenport
Journal:  J Infect Dis       Date:  2016-08-28       Impact factor: 5.226

2.  Poorly cytotoxic terminally differentiated CD56negCD16pos NK cells accumulate in Kenyan children with Burkitt lymphomas.

Authors:  Catherine S Forconi; Cormac P Cosgrove; Pryia Saikumar-Lakshmi; Christina E Nixon; Joslyn Foley; John Michael Ong'echa; Juliana A Otieno; Galit Alter; Christian Münz; Ann M Moormann
Journal:  Blood Adv       Date:  2018-05-22

Review 3.  Malaria - how this parasitic infection aids and abets EBV-associated Burkitt lymphomagenesis.

Authors:  Ann M Moormann; Jeffrey A Bailey
Journal:  Curr Opin Virol       Date:  2016-09-27       Impact factor: 7.090

4.  High pathogen burden in childhood promotes the development of unconventional innate-like CD8+ T cells.

Authors:  Yves T Falanga; Michela Frascoli; Yasin Kaymaz; Catherine Forconi; John Michael Ong'echa; Jeffrey A Bailey; Leslie J Berg; Ann M Moormann
Journal:  JCI Insight       Date:  2017-08-03

5.  Increased Epstein-Barr virus in breast milk occurs with subclinical mastitis and HIV shedding.

Authors:  Armen Sanosyan; David G Rutagwera; Jean-Pierre Molès; Karine Bollore; Marianne Peries; Chipepo Kankasa; Mwiya Mwiya; Thorkild Tylleskär; Nicolas Nagot; Philippe Van De Perre; Edouard Tuaillon
Journal:  Medicine (Baltimore)       Date:  2016-07       Impact factor: 1.889

6.  Asymptomatic Primary Infection with Epstein-Barr Virus: Observations on Young Adult Cases.

Authors:  Rachel J Abbott; Annette Pachnio; Isabela Pedroza-Pacheco; Alison M Leese; Jusnara Begum; Heather M Long; Debbie Croom-Carter; Andrea Stacey; Paul A H Moss; Andrew D Hislop; Persephone Borrow; Alan B Rickinson; Andrew I Bell
Journal:  J Virol       Date:  2017-10-13       Impact factor: 5.103

7.  Human and Epstein-Barr Virus miRNA Profiling as Predictive Biomarkers for Endemic Burkitt Lymphoma.

Authors:  Cliff I Oduor; Mercedeh Movassagh; Yasin Kaymaz; Kiprotich Chelimo; Juliana Otieno; John M Ong'echa; Ann M Moormann; Jeffrey A Bailey
Journal:  Front Microbiol       Date:  2017-03-28       Impact factor: 5.640

8.  Assessment of the Combined Effect of Epstein-Barr Virus and Plasmodium falciparum Infections on Endemic Burkitt Lymphoma Using a Multiplex Serological Approach.

Authors:  Ruth Aguilar; Delphine Casabonne; Cristina O'Callaghan-Gordo; Marta Vidal; Joseph J Campo; Nora Mutalima; Evelina Angov; Sheetij Dutta; Deepak Gaur; Chetan E Chitnis; Virander Chauhan; Angelika Michel; Silvia de Sanjosé; Tim Waterboer; Manolis Kogevinas; Rob Newton; Carlota Dobaño
Journal:  Front Immunol       Date:  2017-10-26       Impact factor: 7.561

Review 9.  The Global Landscape of EBV-Associated Tumors.

Authors:  Claire Shannon-Lowe; Alan Rickinson
Journal:  Front Oncol       Date:  2019-08-06       Impact factor: 6.244

10.  A New Hope for CD56negCD16pos NK Cells as Unconventional Cytotoxic Mediators: An Adaptation to Chronic Diseases.

Authors:  Catherine S Forconi; Cliff I Oduor; Peter O Oluoch; John M Ong'echa; Christian Münz; Jeffrey A Bailey; Ann M Moormann
Journal:  Front Cell Infect Microbiol       Date:  2020-04-21       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.